Administrative Measures on the Registration of IVD Reagents
Article 15 The imported IVD reagents in application for registration or in filing formalities shall have been approved to be listing and sale at the place where the applicant or filing applicant is registered or at the country (region) where the production site is located.
Generally speaking, you should use lots that are produced after the product is registered/listed (whether in the country where the legal manufacturer is located or the country where the actual production is located) for type testing. After obtaining the type test report, you can apply EC approval for your clinical trial, which normally requires you to provide the proof of registration in your country of origin.
------------------------------
Qianqian Zhu RAC
United States
------------------------------
Original Message:
Sent: 26-Oct-2017 11:52
From: Anonymous Member
Subject: China regulations for IVD clinical trials
This message was posted by a user wishing to remain anonymous
Is country of origin approval needed to initiate a clinical trial in China for an IVD that is used as a companion diagnostic?